{
    "id": "dbpedia_8016_0",
    "rank": 94,
    "data": {
        "url": "https://www.theguardian.com/business/pfizer",
        "read_more_link": "",
        "language": "en",
        "title": "The Guardian",
        "top_image": "https://static.guim.co.uk/images/favicon-32x32.ico",
        "meta_img": "https://static.guim.co.uk/images/favicon-32x32.ico",
        "images": [
            "https://sb.scorecardresearch.com/p?c1=2&c2=6035250&cv=2.0&cj=1&cs_ucfr=0&comscorekw=Pfizer",
            "https://i.guim.co.uk/img/media/3bf694005a6dd406aaafe4916de7ab54fddd626b/0_0_8256_4954/master/8256.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/5cad8e95ae190e11b5abad8f16fb7fd06a97be8e/0_89_8781_5268/master/8781.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/40ad224e0afa5af7a19d3c4541959f21a3f98c7f/5_0_3635_2181/master/3635.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/b97723a49b9678b8d436db6f907e70917c008ff7/36_1104_6737_4042/master/6737.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/9f7425435fc60061b08df6aab37bbd0f01a7d1ba/0_315_4684_2810/master/4684.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/959098c5ce0b3cf0d9c83066fb208b4d16fe062e/0_246_4968_2983/master/4968.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/2d60ade3edb4456f1e85945ab7646734d03c880f/0_0_4200_2521/master/4200.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/8bd80f1ae4f3ed5993a9bfed993ff102475d6073/425_761_3937_2364/master/3937.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/36ecb8f72c23076cbb687a71d4b0c630a2cb851f/0_0_2480_1488/master/2480.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/005a6c8b091f940d39ed746e6bdca107485a3357/0_455_5081_3048/master/5081.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/4e29a85677ccf073700705ae3e1063dc85878a3b/0_123_3264_1958/master/3264.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/2045bae186d145f7d1c981bf01b5eb1a1c84d378/0_72_5238_3143/master/5238.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/3500a8a62454d9e473371cb7e173ffb657d69846/0_366_5487_3292/master/5487.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/a0a9b16f2e594c580cd7a94a06a1226d13adbd48/0_297_5238_3143/master/5238.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/088998f3808d62efb27cf174167f367195a47605/27_0_1898_1140/master/1898.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/b7868d26c43c73995efdf12d0a67fe30392c9ad8/0_3_5160_3096/master/5160.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/1b9ff2f246cac75ee75e202621a172b9a1dde1de/0_280_5625_3375/master/5625.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/f5af72389f64d47431ba041c0c4f30ba655cbf07/460_926_4263_2557/master/4263.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/5e58e87c19b647e0937a7b0087a3637a8de9b09d/0_3_5413_3248/master/5413.jpg?width=240&dpr=1&s=none",
            "https://i.guim.co.uk/img/media/e9a1a427fb8fda708f7de989e9b54761b6883148/0_0_1875_1125/master/1875.jpg?width=240&dpr=1&s=none"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2024-02-22T00:01:37+00:00",
        "summary": "",
        "meta_description": "Latest news, sport, business, comment, analysis and reviews from the Guardian, the world&#x27;s leading liberal voice",
        "meta_lang": "en",
        "meta_favicon": "https://assets.guim.co.uk/static/frontend/icons/homescreen/apple-touch-icon.svg",
        "meta_site_name": "",
        "canonical_link": "https://www.theguardian.com/business/pfizer",
        "text": "Drug to treat alopecia recommended for NHS use for first time\n\nRitlecitinib, taken once a day, approved by Nice for severe hair loss caused by autoimmune disease\n\n‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare\n\nObserver investigation shows drug company money flows through the NHS, raising questions about conflict of interest"
    }
}